Nairobi, Kenya, 30 January 2013: The Abraaj Group, a leading private equity investor operating in global growth markets, today announced an investment by its Africa Health Fund in Vine Pharmaceuticals, the largest pharmacy retail chain in Uganda.
The investment is the Africa Health Fund’s first in the pharmaceutical retail and distribution sector. It will help Vine to expand its reach and market share in Uganda’s rapidly growing pharmaceutical market, where expenditure is growing at a CAGR of 13% and forecast to increase from the US$ 268 million spent in 2011 to US$ 545 million by 2014.
The Africa Health Fund was established in June 2009 with the International Finance Corporation, The African Development Bank, DEG, and the Bill & Melinda Gates Foundation as cornerstone investors. The Fund’s unique objective is to improve the access of low-income Africans to affordable, high quality health services while providing investors with strong long-term financial returns. The Africa Health Fund’s strategy is to tackle the issues of fragmentation in private healthcare provision and to drive economies of scale in supporting sectors such as pharmaceuticals, medical devices and diagnostic services.
Vine Pharmaceuticals was founded in 1999 and has grown to be the largest Ugandan pharmacy retailer, with 21 stores, 98 employees and a pharmaceutical import business. Abraaj will support Vine in extending its branch network outside Kampala, and building the capacity of its wholesale distribution business serving clinics, hospitals and other pharmacies.
Shakir Merali, Partner, The Abraaj Group, commented: “Vine will be an important beneficiary of the continued growth in pharmaceutical expenditure in Uganda through both its retail and wholesale businesses.”
“There will also be significant benefits for low-income Ugandans, with more consumers being put within easy reach of the basic health advice that a pharmacy can provide, and improvements to the availability of a comprehensive, up-to-date and affordable supply of drugs and other health products across the country.”
Grace Munyirwa, Founder and Director of Vine Pharmaceuticals, said: “I am proud of the work our team has done to take Vine to its leading position in the Ugandan market, and I am looking forward to taking the business to the next level with Abraaj’s support. Their expertise in the health sector and their track record of helping to grow businesses by investing in operational improvements and more sophisticated business management systems will make them the perfect partners as we expand our presence across the country and develop our promising wholesale business.”
The Abraaj Group is one of the leading private equity investors in the healthcare sector in growth markets around the world. Its Funds’ investments include stakes in the Philippines retail pharmacy chain HBC, and in Saudi Arabia’s Tadawi Group, both leaders in their local markets. Additionally, the Group has current investments in nine hospitals (following two recent successful healthcare exits in Asia), as well as in pharmaceuticals, diagnostics, and medical devices manufacturing.
The Abraaj Group and the Royal College of Art are pleased to welcome five new Abraaj RCA Innovation Scholars for the 2016/17 academic year. Launched in 2014, the Abraaj RCA Innovation Scholarship is the largest-ever international scholarship programme in the postgraduate creative sector, supporting five outstanding RCA applicants across Africa, Asia, Latin America, the Middle East and Turkey every year. more >
The Abraaj Group (‘Abraaj’), a leading investor operating in global growth markets, has been named Private Equity House of the Year for North Africa by Private Equity Africa Awards 2016 at the 5th Annual GP and Advisor Awards. Abraaj was also given a special recognition award for Large Cap Deal of the Year for the North Africa Hospital Holdings Group. more >
Artists from the Middle East, North Africa and South Asia region are invited to apply with a proposal for a new, original, unrealised work that will be revealed at Art Dubai 2017, which takes place March 15-18, 2017. Following an intensive jury process, one winning artist will be awarded a $100,000 prize to create a major new commission. Three shortlisted artists will also be chosen to receive a cash prize of $10,000 and showcase their work alongside the winning work in a thematic exhibition. more >
The Abraaj Group, a leading investor operating in global growth markets, today announced the acquisition, through one of its Funds, of a minority stake in Fibabanka A.S. (‘Fibabanka’ or the ‘Bank), one of the most prominent banks in Turkey with a highly experienced management team. The investment from Abraaj will be used by Fibabanka to expand its franchise and support its growth. more >
After winning the Abraaj Group Art Prize in 2011, Nadia Kaabi-Linke has gone on to have solo shows in The Mosaic Rooms (London), the Calouste Gulbenkian Foundation (Lisbon), Dallas Contemporary (United States) and, most recently, the Solomon R. Guggenheim in New York. In an interview with Art Dubai, Kaabi-Linke spoke about the exhibition, and what the last five years have been like for her since winning the Prize in 2011. more >